发明名称 FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY
摘要 Fibronectin type III (10Fn3) binding domains having novel designs that are associated with reduced immunogenicity are provided. The application describes alternative 10Fn3 binding domains in which certain immunogenic regions are not modified when producing a binder in order to maintain recognition as a self antigen by the host organism. The application also describes 10Fn3 binding domains in which HLA anchor regions have been destroyed thereby reducing the immunogenic contribution of the adjoining region. Also provided are 10Fn3 domains having novel combinations of modified regions that can bind to a desired target with high affinity.
申请公布号 US2015051149(A1) 申请公布日期 2015.02.19
申请号 US201214355155 申请日期 2012.10.31
申请人 BRISTOL-MYERS SQUIBB COMPANY 发明人 Davis Jonathan;Lipovsek Dasa;Camphausen Ray
分类号 C07K14/78 主分类号 C07K14/78
代理机构 代理人
主权项 1. A polypeptide comprising a human fibronectin type 3 tenth (10Fn3) domain, wherein the 10Fn3 domain comprises (i) a modification in the amino acid sequence of at least one north pole loop selected from the BC, DE and FG loops relative to the corresponding loop of the wild-type human 10Fn3 domain (SEQ ID NO: 1 or 6), and (ii) a modification in the amino acid sequence of at least one south pole loop selected from the AB, CD and EF loops relative to the corresponding loop of the wild-type human 10Fn3 domain (SEQ ID NO: 1 or 6), wherein the at least one modified north pole loop and the at least one modified south pole loop contribute to binding the same target.
地址 Princeton NJ US
您可能感兴趣的专利